2020 annual financial data
Tarsus Pharmaceuticals 2020 Operating margin
Tarsus Pharmaceuticals 2020 operating margin with verified reported values.
Direct answer
Operating margin was -80.71%.
Operating income was -26,983,000 USD and net income was -26,811,000 USD.
Operating cash flow was -21,138,000 USD.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,432,000 USD
- Operating income
- -26,983,000 USD
- Net income
- -26,811,000 USD
- Operating cash flow
- -21,138,000 USD